THE USE OF CEFACEL IN THE TREATMENT OF CHRONIC AUTOIMMUNE THYROIDITIS

Authors

  • Prylutsky A. S. Donetsk National Medical University named after Горького; DOCTMENT
  • Kasyarum V. P. Donetsk National Medical University named after Горького; DOCTMENT
  • Prylutska O. A. Donetsk National Medical University named after Горького; DOCTMENT;
  • Degonsky A. I. Donetsk National Medical University named after Горького; DOCTMENT;
  • Knyshevska L. A. Donetsk National Medical University named after Горького; DOCTMENT;
  • Bakhtiyarova A. A. Donetsk National Medical University named after Горького; DOCTMENT;
  • Pyskureva A. V. Donetsk National Medical University named after Горького; DOCTMENT;
  • Vasylieva V. V. Donetsk National Medical University named after Горького; DOCTMENT;
  • Galkina N. S. City Endocrinology Dispensary, Donetsk
  • Lesnichenko D. A. City Endocrinology Dispensary, Donetsk

DOI:

https://doi.org/10.21856/j-PEP.2011.3.04

Keywords:

autoimmune thyroiditis, antibodies to thyroperoxidase, antibodies to thyroglobulin, treatment, Cefasel

Abstract

The levels of specific autoantibodies to thyroperoxidase and thyroglobulin were studied in 40 patients with chronic autoimmune thyroiditis before and after treatment with sodium selenite (Cefasel 200 μg per day). Treatment with Cefasel for three months against the background of levothyroxine therapy caused a significant decrease in the level of antibodies to thyroperoxidase and thyroglobulin.

References

Аутоиммунные заболевания щитовидной железы: состояние проблемы [Текст] / И. И. Дедов, Е. А. Трошина, С. С. Антонова [и др.] // Пробл. эндокринологии. — 2002. — № 2. — С. 6–8.

Вагапова, Г. Р. Применение магнитно-резонансной томографии в диагностике заболеваний щитовидной железы [Текст] / Г. Р. Вагапова, И. М. Михайлов // Мед. визуализация. — 2006. — № 3. — С. 15–20.

Петрушина, Н. А. Клиника, диагностика и лечение аутоиммунного тиреоидита [Текст] / Н. А. Петрушина // Пробл. ндокринологии. — 2009. — № 36. — С. 16–21.

Rayman, M. P. The importance of selenium to human health [Text] / M. P. Rayman // Lancet. — 2000. — Vol. 356. — P. 233–241.

Marokopakis, E. E. Hashimoto’s thyroiditis and role of selenium. Current concepts [Text] / E. Marokopakis, W. Chanzipavlidou // Hell. J.

Nucl. Med. — 2007. — Vol. 10 (1). — P. 6–8.

Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population [Text] / B. Contempre, N. L. Duale, J. E. Dumont, B. Ngo // Clin. Endocrinol. — 1992. — Vol. 36. — P. 579–583.

Goyens, P. Selenium deficiency as a possible factor in the patogenesis of myxoedematous endemic cretinism [Text] / P. Goyens, J. Golstein, Nsombola // Endocrinology. — 2002. — Vol. 144. — P. 497– 502.

Chole, A. Selenium and signal transduction: road to cell death and anti-tumor activity biofactors [Text] / A. Chole, J. Fleming, P. R. Harrison // Acta Endocrinology. — 2001. — Vol. 14. — P. 127–133.

Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations [Text] / R. Garther, B. Gashier, J. Dietrich [et al.] // J. Clin. Endocrinol. Metabol. — 2002. — Vol. 87. — P. 1687–1691.

Autoimmune thyroid diseases [Text] / P. Caturegli, H. Kimura, R. Rocchi [et al.] // Curr. Opin. Rheumatol. — 2005. — Vol. 19. — P. 4–8.

Duntas, L. Effects of six month treatment with selenomethionine in the patient with autoimmune thyroiditis [Text] / L. Duntas, E. Mantzou, D. Koutras // Europ. J. Endocrinol. — 2003. — Vol. 148. — P. 389–393.

Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations [Text] / R. Gärtner, B. C. Gasnier, J.W. Dietrich [et al.] // J. Clin. Endocrinol. Metabol. — 2002. — Vol. 87, № 4. — P. 1687–1691.

Downloads

Published

2011-09-27

How to Cite

Prylutsky, A. S., Kasyarum, V. P., Prylutska, O. A., Degonsky, A. I., Knyshevska, L. A., Bakhtiyarova, A. A., Pyskureva, A. V., Vasylieva, V. V., Galkina, N. S., & Lesnichenko, D. A. (2011). THE USE OF CEFACEL IN THE TREATMENT OF CHRONIC AUTOIMMUNE THYROIDITIS. Problems of Endocrine Pathology, 37(3), 22-26. https://doi.org/10.21856/j-PEP.2011.3.04

Issue

Section

CLINICAL ENDOCRINOLOGY

Most read articles by the same author(s)